Giuseppe Speziale

Giuseppe Speziale

Auto-generated profile, based on publicly available information

Giuseppe Speziale

Division of Cardiac Surgery, GVM Care & Research, Bari, Italy

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2000 in The Thoracic and Cardiovascular Surgeon
Verified
Journal Article
Closed access
GSG. Speziale
G. Speziale
GRG. Ruvolo
G. Ruvolo
KFK. Fattouch
K. Fattouch
FMF. Macrina
F. Macrina
ETE. Tonelli
E. Tonelli
BMB. Marino
B. Marino
Background: Arrhythmias are common after open heart surgery and may be related to hypomagnesaemia due to cardiopulmonary bypass. Although perioperative prophylactic Mg2+ administration may prevent arrhythmias after coronary artery bypass grafting (CABG), clear indications as well as the timing of Mg2+ substitution and dose regimen need to be clarified. Aim of this study was to evaluate the antiarrhythmic effects of Mg2+ infusion in patients who underwent elective CABG. Method: Ninety-seven patients who underwent elective CABG were divided in four Groups. In Group A 1 g of magnesium sulfate was added to the pump prime, Group B received 1 g in the pump prime plus 5 mmol/L in the cardioplegic solution, Group C received 5 mmol/L in the cardioplegic solution, and Group D was a placebo control Group. Groups A, B, and C also received 24 h continuous infusion of magnesium sulfate at 10 mmol/L. Three-channel electrocardiogram (II-V5-V6) continuous monitoring was performed 12 hours preoperatively and 48 hours postoperatively. Blood samples were taken for subsequent Serum magnesium measurements, at five different time points before, during and after CBP. Results: In all Groups serum Mg2+ levels were reduced during CPB (Time 2) and statistically significant differences from pre-anaesthesia levels (Time 1) were noted (p < 0.05). In Groups A, B, and C Serum Mg2+ levels increased progressively from Time 3 to Time 5; in Group D serum Mg2+ levels were still much lower at Time 5. Significant differences (p < 0.05) were noted for Groups B and C vs Groups A and D in atrial ectopics, atrial fibrillation, and ventricular arrhythmic events. Conclusion: Our results demonstrate that Mg2+ sulfate administration regimens used in Group B and C reduce postoperative arrhythmic events in patients undergoing CABG.

31 August 2011 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
Giuseppe NassoGiuseppe Nasso
Giuseppe Nasso
RBRaffaele Bonifazi
Raffaele Bonifazi
APArmando Del Prete
Armando Del Prete
GPGiuseppe Del Prete
Giuseppe Del Prete
VLVincenzo Lopriore
Vincenzo Lopriore
GSGiuseppe Speziale
Giuseppe Speziale

Verified
Journal Article
Open access
PDF file
RGRiccioni Graziano
Riccioni Graziano
Luca ScottiLuca Scotti
Luca Scotti
NDNicolantonio D'Orazio
Nicolantonio D'Orazio
SGSabina Gallina
Sabina Gallina
GSGiuseppe Speziale
Giuseppe Speziale
TBTonino Bucciarelli
Tonino Bucciarelli
Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase (NOS) inhibitor known as a mediator of endothelial dysfunction and atherosclerosis. Circulating ADMA levels are correlated with cardiovascular risk factors such as hypercholesterolemia, arterial hypertension, diabetes mellitus, hyperhomocysteinemia, age and smoking. We assessed the relationship between ADMA values and site-specific association of asymptomatic carotid atherosclerosis (intima-media thickness (CIMT) and plaque) in elderly subjects. One hundred and eighty subjects underwent a complete history and physical examination, determination of serum chemistries and ADMA levels, and carotid ultrasound investigation (CUI). All subjects had no acute or chronic symptoms of carotid atherosclerosis. Statistical analyses showed that high plasma levels of ADMA/SDMA were positively correlated to carotid atherosclerosis (CIMT and plaque) (p < 0.001), with significant site-specific association. Total cholesterol, low density lipoprotein cholesterol, triglycerides and C-reactive protein plasma concentrations were significantly associated with asymptomatic carotid atherosclerosis (p < 0.001). High serum concentrations of ADMA and SDMA were associated with carotid atherosclerotic lesions as measured by CIMT ad plaque and may represent a new marker of asymptomatic carotid atherosclerosis in elderly subjects.

1 June 2008 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
KFkhalil fattouch
khalil fattouch
RSRoberta Sampognaro
Roberta Sampognaro
GBGiuseppe Bianco
Giuseppe Bianco
ENEmiliano Navarra
Emiliano Navarra
MMMarco Moscarelli
Marco Moscarelli
GRGiovanni Ruvolo
Giovanni Ruvolo

1 May 2000 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
GSG Speziale
G Speziale
Total arterial myocardial revascularization may be achieved by using the 'Y-graft' techniques with different free arterial conduits anastomosed off the side of an in situ internal thoracic artery to reach distal coronary segments. This study was assessed to measure intraoperative graft flow, resistance and clinical outcomes. Seventy-six patients who underwent coronary artery bypass grafting during a time period of 27 months were enrolled in this prospective study. All patients received sequential grafting by using both internal thoracic arteries, inferior epigastric and right gastroepiploic artery joined as a composite Y graft. Intraoperative graft flow, resistance and derived variables were measured. All patients except one showed good flow (ml/min and waveform) in either branch of composite graft. In one case, a low-flow situation through the graft was registered requiring surgical correction. Temporary occlusion of either branch did not significantly affect flow in the other side of the arterial Y. Mid-term follow-up (3 and 15 months) and angiographic studies showed a high graft patency rate. Composite arterial grafts provide excellent early and mid-term clinical results. Flow reserve of the left internal thoracic artery did not affect blood flow and resistance on either branch of the Y graft when temporary occlusion on the other side of the arterial Y was performed.

12 June 2012 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
Giuseppe NassoGiuseppe Nasso
Giuseppe Nasso
GPGeorges Popoff
Georges Popoff
MLMauro Lamarra
Mauro Lamarra
VRVito Romano
Vito Romano
RCRoberto Coppola
Roberto Coppola
GSGiuseppe Speziale
Giuseppe Speziale
Background and aim: A debate over alternative therapeutic strategies for multivessel coronary disease is currently ongoing. We aimed at analyzing the results of myocardial revascularization with arterial conduits. Methods: We retrospectively reviewed 10,752 patients undergoing isolated coronary bypass surgery within our hospital's group. Average follow‐up was 37.2 months. Through propensity‐matching, we generated three groups (3584 patients each) on the basis of the revascularization strategy: use of one mammary artery plus venous grafts, use of two mammary arteries plus venous graft, and total arterial revascularization. Results: Overall operative mortality was 2.8%. Patient‐related factors (renal failure, advanced age, recent myocardial infarction, depressed LVEF, diabetes) were identified as predictors of mortality (logistic regression). Although mortality was not statistically different among groups, patients receiving more than one arterial conduit displayed in the long‐term better freedom from cardiac death and from adverse cardiac events (repeat revascularization, myocardial infarction, recurrent angina) (Kaplan–Meier analysis). Use of only one arterial conduit, diabetes and depressed LVEF predicted cardiac mortality, and adverse events (Cox regression). No differences in any endpoint emerged among patients receiving two arterial conduit plus venous grafts or total arterial revascularization. Conclusions: These data strongly support the practice of using two arterial conduits rather than one. The operative and late results of coronary surgery with arterial conduits are optimal and should serve as a current benchmark for the comparison with state‐of‐the‐art percutaneous interventions. (J Card Surg 2012;27:427‐433)